trending Market Intelligence /marketintelligence/en/news-insights/trending/K4ODf4O8EXjRzcWn8tnlVg2 content esgSubNav
In This List

NovoCure director to retire

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


NovoCure director to retire

Robert Mylod intends to retire as a class II director of NovoCure Ltd., at the company's 2017 annual general meeting of shareholders.

Mylod's decision was not a result of any dispute with the company or its management. He has served on the company's board for five years.